Advanced search×

Implementation of the biosimilar pathway: economic and policy issues.

Henry H Grabowski, Genia G Long, and Richard R Mortimer

Seton Hall Law Rev 41(2):511-57 (2011) PMID 21739758

Version: za2963e q8za5 q8zb5 q8zc8 q8zd1 q8ze7 q8zfd q8zg6
Buy PDF

Similar articles you may find interesting…

  1. Factors Affecting Kyphotic Angle Reduction in Osteoporotic Vertebral Compression Fractures with Kyphoplasty.
    Minjie Shen, Heng Wang, and Huilin Yang

    Orthopedics 36(4):e509-e514 (2013) PMID 23590794

    This article describes the independent factors that affect kyphotic angle reduction in the treatment of osteoporotic vertebral compression fractures with kyphoplasty. Between January 2008 and September 2011, one hundred twenty-six patients with a single-level osteoporotic compression...
    Buy PDF
  2. Association between teriparatide adherence and healthcare utilization and costs in real-world US kyphoplasty/vertebroplasty patients.
    Y Zhao, S S Johnston, and J Krege

    Osteoporos Int (2013) PMID 23529293

    Among KV patients initiating teriparatide, significantly increased pharmacy costs associated with high teriparatide adherence were offset by significantly lower inpatient utilization and medical costs....
    Buy PDF
  3. Novel use of propranolol for management of pain in children with vertebral hemangioma: report of two cases.
    Didem Uzunaslan, Caner Saygin, and Tiraje Celkan

    Childs Nerv Syst (2013) PMID 23306960

    Vertebral hemangioma (VH) is an exceedingly rare neoplasm in pediatric population with less than 10 cases reported in the literature. It is usually asymptomatic in adults and diagnosed incidentally at radiographic investigations of other medical conditions. In this report, we describe two children w...
    Buy PDF